|
業務類別
|
Biotechnology |
|
業務概覽
|
ETHZilla Corporation is a technology company in the decentralized finance industry. It seeks to connect financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It generates recurring revenues through various DeFi protocols that improve Ethereum network integrity and security. The group enables the seamless tokenization of traditional assets by bringing them on-chain. Leveraging its proprietary protocol solutions, ETHZilla supports DeFi transactions, asset digitization across various Layer 2 Ethereum networks. The platform is focused on delivering tokenization services, DeFi protocol integrations, blockchain analytics, gateways for converting traditional assets to digital forms. |
| 公司地址
| 2875 South Ocean Boulevard, Suite 200, Palm Beach, FL, USA, 33480 |
| 電話號碼
| +1 650 507-0669 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.180lifesciences.com |
| 員工數量
| 3 |
| Mr. McAndrew Rudisill |
Executive Chairman of the Board and Chief Executive Officer |
-- |
05/09/2025 |
| Mr. Ozan Pamir |
Chief Financial Officer and Secretary |
美元 387.74K |
12/09/2024 |
| Mr. Eric R. Van Lent |
Chief Accounting Officer and Principal Financial Officer |
-- |
21/02/2025 |
| Dr. James N. Woody, M.D.,PhD |
Chief Executive Officer and Director |
美元 463.50K |
25/03/2024 |
| Mr. Quan Anh Vu |
Chief Operating Officer and Chief Business Officer |
美元 65.00K |
28/04/2022 |
| Mr. Blair Jordan |
Chief Executive Officer and Director |
美元 140.11K |
21/02/2025 |
| Dr. Jonathan Rothbard, PhD |
Chief Scientific Officer |
美元 268.91K |
23/05/2023 |
| Mr. Omar Jimenez |
Chief Financial Officer |
-- |
12/09/2024 |
| Mr. John Tazewell Saunders |
Chief Financial Officer, Chief Accounting Officer and Secretary |
-- |
14/11/2025 |
|
|
| Mr. Francis Knuettel, II |
Independent Director |
23/05/2023 |
| Mr. McAndrew Rudisill |
Executive Chairman of the Board and Chief Executive Officer |
05/09/2025 |
| Ms. Crystal Heter |
Independent Director |
05/08/2025 |
| Mr. Ryan L. Smith |
Lead Independent Director |
07/02/2025 |
| Mr. Jay Goodman |
Independent Director |
31/03/2025 |
| Mr. Stephen H. Shoemaker |
Independent Director |
07/07/2025 |
| Mr. Michael A Edwards |
Independent Director |
19/12/2025 |
| Professor Marc Feldmann, PhD |
Executive Co-Chairman of the Board |
23/05/2023 |
| Mr. Russell T. Ray, M.B.A. |
Independent Director |
23/05/2023 |
| Mr. Donald A. McGovern, Jr |
Lead Independent Director |
23/05/2023 |
| Dr. James N. Woody, M.D.,PhD |
Chief Executive Officer and Director |
25/03/2024 |
| Mr. Jason G. New |
Director |
08/10/2025 |
| Professor Lawrence J. Steinman, M.D. |
Director |
07/07/2025 |
| Mr. Blair Jordan |
Chief Executive Officer and Director |
21/02/2025 |
| Mr. Andrew Suckling |
Independent Director |
05/08/2025 |
| Dr. Larry Gold, PhD |
Independent Director |
23/05/2023 |
| Dr. Pamela G. Marrone, PhD |
Independent Director |
23/05/2023 |
| Ms. Angela Dalton |
Independent Director |
19/12/2025 |
| Ms. Teresa M. DeLuca, M.D. |
Independent Director |
23/05/2023 |
|
|
|
|
